IBDEI22I ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1765,0)
 ;;=AUDITORY^2^160
 ;;^UTILITY(U,$J,358.4,1766,0)
 ;;=COGNITION^7^160
 ;;^UTILITY(U,$J,358.4,1767,0)
 ;;=PSYCHIATRIC-PSYCHOSOC-EMOTIONAL^18^160
 ;;^UTILITY(U,$J,358.4,1768,0)
 ;;=BACK DIAGNOSIS^3^160
 ;;^UTILITY(U,$J,358.4,1769,0)
 ;;=EXTREMITY DIAGNOSIS^9^160
 ;;^UTILITY(U,$J,358.4,1770,0)
 ;;=POST JOINT REPLACEMENT^17^160
 ;;^UTILITY(U,$J,358.4,1771,0)
 ;;=OTHER^15^160
 ;;^UTILITY(U,$J,358.4,1772,0)
 ;;=BLINDNESS^4^160
 ;;^UTILITY(U,$J,358.4,1773,0)
 ;;=SPINAL CORD INJURY^20^160
 ;;^UTILITY(U,$J,358.4,1774,0)
 ;;=IMMUNIZATION^3^161
 ;;^UTILITY(U,$J,358.4,1775,0)
 ;;=BEHAVIOR CHANGE INTERVENTION,INDIVIDUAL^1^161
 ;;^UTILITY(U,$J,358.4,1776,0)
 ;;=COUNSELING RISK FACTOR REDUCTION^2^161
 ;;^UTILITY(U,$J,358.4,1777,0)
 ;;=OTH PREVENTIVE MEDICINE SERVICES^4^161
 ;;^UTILITY(U,$J,358.4,1778,0)
 ;;=PREVENTIVE MEDICINE,GROUP^7^161
 ;;^UTILITY(U,$J,358.4,1779,0)
 ;;=PREVENTIVE HEALTH VISIT-EST PT^5^161
 ;;^UTILITY(U,$J,358.4,1780,0)
 ;;=PREVENTIVE HEALTH VISIT-NEW PT^6^161
 ;;^UTILITY(U,$J,358.4,1781,0)
 ;;=CARDIOVASCULAR^2^162
 ;;^UTILITY(U,$J,358.4,1782,0)
 ;;=ENDOCRINE/METABOLIC^6^162
 ;;^UTILITY(U,$J,358.4,1783,0)
 ;;=PULMONARY^19^162
 ;;^UTILITY(U,$J,358.4,1784,0)
 ;;=EENT^5^162
 ;;^UTILITY(U,$J,358.4,1785,0)
 ;;=MUSCULOSKELETAL^14^162
 ;;^UTILITY(U,$J,358.4,1786,0)
 ;;=NEURO^15^162
 ;;^UTILITY(U,$J,358.4,1787,0)
 ;;=MENTAL HEALTH^13^162
 ;;^UTILITY(U,$J,358.4,1788,0)
 ;;=GASTROENTEROLOGY^7^162
 ;;^UTILITY(U,$J,358.4,1789,0)
 ;;=GU / RENAL^8^162
 ;;^UTILITY(U,$J,358.4,1790,0)
 ;;=WOMEN'S HEALTH^21^162
 ;;^UTILITY(U,$J,358.4,1791,0)
 ;;=HEMATOLOGY/ONCOLOGY^9^162
 ;;^UTILITY(U,$J,358.4,1792,0)
 ;;=INFECTIOUS DISEASE^11^162
 ;;^UTILITY(U,$J,358.4,1793,0)
 ;;=DERMATOLOGY^4^162
 ;;^UTILITY(U,$J,358.4,1794,0)
 ;;=HISTORY OF ILLNESS^10^162
 ;;^UTILITY(U,$J,358.4,1795,0)
 ;;=PREVENTIVE HEALTH/SCREENINGS^1^162
 ;;^UTILITY(U,$J,358.4,1796,0)
 ;;=INJURY/TRAUMA^12^162
 ;;^UTILITY(U,$J,358.4,1797,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^20^162
 ;;^UTILITY(U,$J,358.4,1798,0)
 ;;=SEXUAL TRAUMA^19^162
 ;;^UTILITY(U,$J,358.4,1799,0)
 ;;=PAIN^17^162
 ;;^UTILITY(U,$J,358.4,1800,0)
 ;;=OTHER REASONS^16^162
 ;;^UTILITY(U,$J,358.4,1801,0)
 ;;=CAUSES OF INJURY (SECONDARY ONLY)^3^162
 ;;^UTILITY(U,$J,358.4,1802,0)
 ;;=ESOPHAGUS^4^163
 ;;^UTILITY(U,$J,358.4,1803,0)
 ;;=LYMPH NODES (SECONDARY)^6.5^163
 ;;^UTILITY(U,$J,358.4,1804,0)
 ;;=LARYNX^6.4^163
 ;;^UTILITY(U,$J,358.4,1805,0)
 ;;=LUNG^6.41^163
 ;;^UTILITY(U,$J,358.4,1806,0)
 ;;=MELANOMA^6.6^163
 ;;^UTILITY(U,$J,358.4,1807,0)
 ;;=GENITOURINARY^.5^163
 ;;^UTILITY(U,$J,358.4,1808,0)
 ;;=BRAIN^.7^163
 ;;^UTILITY(U,$J,358.4,1809,0)
 ;;=BREAST-FEMALE^.6^163
 ;;^UTILITY(U,$J,358.4,1810,0)
 ;;=HYPOPHARYNX^6.1^163
 ;;^UTILITY(U,$J,358.4,1811,0)
 ;;=CONNECTIVE & SOFT TISSUE^2^163
 ;;^UTILITY(U,$J,358.4,1812,0)
 ;;=RADIATION FOLLOW-UP^.45^163
 ;;^UTILITY(U,$J,358.4,1813,0)
 ;;=MOUTH^8^163
 ;;^UTILITY(U,$J,358.4,1814,0)
 ;;=MOUTH-FLOOR^9^163
 ;;^UTILITY(U,$J,358.4,1815,0)
 ;;=NASOPHARYNX^10^163
 ;;^UTILITY(U,$J,358.4,1816,0)
 ;;=OROPHARYNX^11^163
 ;;^UTILITY(U,$J,358.4,1817,0)
 ;;=PANCREAS^12^163
 ;;^UTILITY(U,$J,358.4,1818,0)
 ;;=RECTUM/ANUS^13^163
 ;;^UTILITY(U,$J,358.4,1819,0)
 ;;=SALIVARY GLANDS^14^163
 ;;^UTILITY(U,$J,358.4,1820,0)
 ;;=SECONDARY MALIGNANT NEOPLASMS^15^163
 ;;^UTILITY(U,$J,358.4,1821,0)
 ;;=TONGUE^16^163
 ;;^UTILITY(U,$J,358.4,1822,0)
 ;;=MISCELLANEOUS^18^163
 ;;^UTILITY(U,$J,358.4,1823,0)
 ;;=BENIGN NEOPLASMS^.47^163
 ;;^UTILITY(U,$J,358.4,1824,0)
 ;;=RADIATION TREATMENT^.2^163
 ;;^UTILITY(U,$J,358.4,1825,0)
 ;;=PERSONAL HISTORY CA^19^163
 ;;
 ;;$END ROU IBDEI22I
